|
EIF2C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.422300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.710000E-02 |
| Normal-vs-Stage2 |
3.291600E-01 |
| Normal-vs-Stage3 |
2.805800E-01 |
| Normal-vs-Stage4 |
2.288100E-02 |
| Stage1-vs-Stage2 |
7.136200E-01 |
| Stage1-vs-Stage3 |
8.268000E-01 |
| Stage1-vs-Stage4 |
1.123560E-01 |
| Stage2-vs-Stage3 |
8.869600E-01 |
| Stage2-vs-Stage4 |
7.618300E-02 |
| Stage3-vs-Stage4 |
1.409360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.161800E-02 |
| Normal-vs-AfricanAmerican |
4.436100E-02 |
| Normal-vs-Asian |
6.952000E-04 |
| Caucasian-vs-AfricanAmerican |
4.951400E-01 |
| Caucasian-vs-Asian |
1.082170E-01 |
| AfricanAmerican-vs-Asian |
1.234790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.439000E-03 |
| Normal-vs-Female |
5.859600E-01 |
| Male-vs-Female |
6.802600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.056400E-01 |
| Normal-vs-Extreme_Weight |
6.298300E-03 |
| Normal-vs-Obese |
4.102200E-01 |
| Normal-vs-Extreme_Obese |
6.995700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.185400E-01 |
| Normal_Weight-vs-Obese |
5.459800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.103600E-01 |
| Extreme_Weight-vs-Obese |
9.008000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.435600E-01 |
| Obese-vs-Extreme_Obese |
4.010600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.154400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.770400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.964300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.754500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.299400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.277800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.163400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.842500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.696200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.389600E-02 |
| Normal-VS-Type2 PRCC |
5.031900E-02 |
| Normal-VS-KIRP CIMP |
4.354400E-01 |
| Normal-VS-Unclassified PRCC |
4.442400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.873600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.159000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.456300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.202600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.018000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.763400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.136400E-03 |
| Normal-vs-N1 |
2.837000E-01 |
| Normal-vs-N2 |
9.426400E-01 |
| N0-vs-N1 |
5.132800E-01 |
| N0-vs-N2 |
2.581800E-01 |
| N1-vs-N2 |
6.258000E-01 |
|
|
